Clary BM - Search Results

1

Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.

Clary BM, Coveney EC, Philip R, Blazer DG 3rd, Morse M, Gilboa E, Lyerly HK. Clary BM, et al. Cancer Gene Ther. 1997 Mar-Apr;4(2):97-104. Cancer Gene Ther. 1997. PMID: 9080118

2

Active immunotherapy with transiently transfected cytokine-secreting tumor cells inhibits breast cancer metastases in tumor-bearing animals.

Coveney E, Clary B, Iacobucci M, Philip R, Lyerly K. Coveney E, et al. Surgery. 1996 Aug;120(2):265-72; discussion 272-3. doi: 10.1016/s0039-6060(96)80297-2. Surgery. 1996. PMID: 8751592

3

Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines.

Clary BM, Coveney EC, Blazer DG 3rd, Philip R, Lyerly HK. Clary BM, et al. Surgery. 1996 Aug;120(2):174-81. doi: 10.1016/s0039-6060(96)80285-6. Surgery. 1996. PMID: 8751580

4

Active immunization with tumor cells transduced by a novel AAV plasmid-based gene delivery system.

Clary BM, Coveney EC, Blazer DG 3rd, Philip R, Philip M, Morse M, Gilboa E, Lyerly HK. Clary BM, et al. J Immunother. 1997 Jan;20(1):26-37. doi: 10.1097/00002371-199701000-00003. J Immunother. 1997. PMID: 9101411

5

Gene therapy and pancreatic cancer.

Clary BM, Lyerly HK. Clary BM, et al. Surg Oncol Clin N Am. 1998 Jan;7(1):217-49. Surg Oncol Clin N Am. 1998. PMID: 9443997 Review.

6

Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer.

Philip R, Clary B, Brunette E, Kilinski L, Murugesh D, Sorich M, Yau J, Lebkowski J, Lyerly HK, Philip M. Philip R, et al. Clin Cancer Res. 1996 Jan;2(1):59-68. Clin Cancer Res. 1996. PMID: 9816091

7

Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations.

Osada T, Chen M, Yang XY, Spasojevic I, Vandeusen JB, Hsu D, Clary BM, Clay TM, Chen W, Morse MA, Lyerly HK. Osada T, et al. Among authors: clary bm. Cancer Res. 2011 Jun 15;71(12):4172-82. doi: 10.1158/0008-5472.CAN-10-3978. Epub 2011 Apr 29. Cancer Res. 2011. PMID: 21531761 Free PMC article.

8

Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancer.

Kim MK, Osada T, Barry WT, Yang XY, Freedman JA, Tsamis KA, Datto M, Clary BM, Clay T, Morse MA, Febbo PG, Lyerly HK, Hsu DS. Kim MK, et al. Among authors: clary bm. Mol Cancer Ther. 2012 Jul;11(7):1500-1509. doi: 10.1158/1535-7163.MCT-11-0937. Epub 2012 Feb 16. Mol Cancer Ther. 2012. PMID: 22351745 Free PMC article.

9

Generation of tumor-specific T lymphocytes for the treatment of posttransplant lymphoma.

DiMaio JM, Van Trigt P, Gaynor JW, Davis RD, Coveney E, Clary BM, Lyerly HK. DiMaio JM, et al. Among authors: clary bm. Circulation. 1995 Nov 1;92(9 Suppl):II202-5. doi: 10.1161/01.cir.92.9.202. Circulation. 1995. PMID: 7586409

10

Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo.

DiMaio JM, Clary BM, Via DF, Coveney E, Pappas TN, Lyerly HK. DiMaio JM, et al. Among authors: clary bm. Surgery. 1994 Aug;116(2):205-13. Surgery. 1994. PMID: 8047987

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters